Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret the clinical significance of somatic mutations in cancer. The tool, known as CancerVar, incorporates machine learning...

February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...

Small Business Innovation Research Program Seed Funding will Support R&D to Improve Coronavirus Testing Methodology BALTIMORE--(BUSINESS WIRE)--xMD Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business...

Delivering faster, more accurate and efficient tissue dissection Eindhoven, THE NETHERLANDS (July 20, 2021) – Xyall BV, a leading medtech innovator in molecular pathology, launches its Tissector High Throughput (HT) system for greater...

Partnership to leverage Illumina's extensive decentralised installed base with Roche's expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves...

Date: Wednesday, February 24 Time: 9:00 AM (PT) Speaker: Claire Ray Associate Product Manager Oncology, Illumina Abstract: Next-generation sequencing (NGS) can help you avoid costly and time-consuming iterative testing while...